All “necessary precautions” were taken to prevent disruption to the manufacture of the Oxford/AstraZeneca coronavirus vaccine, following “mild flooding” at a plant where it is produced.
Excess water surrounded buildings at Wockhardt’s pharmaceutical manufacturing facility on Wrexham Industrial Estate, according to a spokeswoman for the firm.
“Last night at approximately 1600 hours Wockhardt UK experienced mild flooding, resulting in excess water surrounding part of the buildings across site,” the spokeswoman said in a statement.
“All necessary precautions were taken, meaning no disruption to manufacturing or inlet of water into buildings.
“The site is now secure and free from any further flood damage and operating as normal.”
